BNP Paribas Exane upgraded Hypoport (HYPOF) to Outperform from Neutral with a EUR 210 price target The firm sees strong earnings growth ahead of the company.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks